A fractionation apparatus comprises two channels coupled through a semipermeable membrane. A time and position dependent concentration of precipitation reagent is produced in one of the channels. sample entities such as macromolecules or cells introduced into this channel are eluted therefrom at different times depending on their solubility or mobility in the presence of the precipitation reagent.
|
14. A fractionation apparatus comprising:
a first channel containing a sample for fractionation; a second channel containing a substantially saturated solution of a precipitating salt and coupled to a soure of said salt; and a semi-permeable membrane separating said first channel from said second channel.
24. A method of separating molecules having one or more different properties comprising:
introducing a substantially saturated solution of precipitating salt into a first flow channel; introducing a sample into a second flow channel which is separated from said first flow channel by a semi-permeable membrane.
1. A protein fractionation apparatus comprising:
a source of precipitating salt; a first channel coupled to said source such that the concentration of precipitating salt in said channel varies substantially continuously along the length of said channel; and a protein detector coupled to an output of said first channel.
18. A method of sample fractionation comprising:
varying a concentration of a precipitation reagent from a first end of a channel to a second end of a channel; introducing a sample into said first end of said channel; and eluting said sample from said second end of said channel by reducing the concentration of said precipitation reagent throughout said channel.
22. A fractionation apparatus comprising a source of precipitating salt:
a sample flow channel coupled to said source; means for forming a continuously spatially increasing precipitating salt concentration from a first portion of said channel to a second portion of said channel so as to selectively precipitate a plurality of different chemical species at different locations of said channel; and means for producing a timewise reduction in precipitating salt concentration throughout said channel so as to elute at least some of said plurality of different chemical species from said channel at different times.
8. A fractionation apparatus comprising:
a first channel comprising a solution containing a substance selected from the group consisting of precipitating salt, organic solvent, acid, base, and polymer and coupled to a source there of, wherein the concentration of said substance in said first channel is approximately constant with position along said first channel; a second channel coupled to said first channel through a semi-permeable membrane, so as to receive a portion of said substance, whereby said second channel has therein a solution of said substance in which the concentration of said substance in said second channel arises from diffusion of said substance through the membrane, wherein the concentration of said substance in said second channel is substantially different at a first position in said second channel than at a second position in said second channel; and a gradient pump configured to produce a timewise reduction in concentration of said substance throughout said second channel.
3. The apparatus of
4. The apparatus of
5. The apparatus of
6. The apparatus of
7. The apparatus of
10. The apparatus of
11. The apparatus of
12. The apparatus of
13. The apparatus of
15. The apparatus of
16. The apparatus of
17. The apparatus of
19. The method of
20. The method of
21. The method of
23. The apparatus of
26. The method of
27. The method of
28. The method of
|
1. Field of the Invention
The invention relates to fractionation apparatus and methods, and finds especially advantageous application to the separation of biological macromolecules.
2. Description of the Related Art
The separation and purification of biological macromolecules is an important aspect of biochemical research and pharmaceutical development. Accordingly, a wide variety of procedures have been developed to isolate desired molecular species from a crude sample of biological material such as a cell lysate. These methods include electrophoresis, elution through a chromatography column, field-flow fractionation, and sequential precipitation techniques, to name a few. In most instances, performing a series of several different separation steps is required in the process of isolating a desired molecule from an initial sample of raw biological material.
Among the various separation protocols mentioned above, the sequential precipitation techniques are both commonly performed and labor intensive. One specific precipitation technique, ammonium sulfate precipitation, has been estimated to be part of approximately 80% of the currently developed protein purification protocols. In this technique, purification is performed by sequentially precipitating sample fractions in solutions having either a progressively higher or a progressively lower concentration of ammonium sulfate. This process requires a large amount of tedious manual preparation of ammonium sulfate solutions as well as manual fraction collection and re-precipitation.
Thus, in contrast with many other molecular separation techniques which may be relatively highly automated, precipitation based separation methods remain labor intensive and highly time consuming.
The invention provides a significant increase in the speed and efficiency of precipitation based fractionation apparatus and methods. In one embodiment, the invention comprises a channel having therein a solution of a precipitation reagent, wherein the concentration of the precipitation reagent is different at a first position in the channel than at a second position in the channel. The concentration at any given point in the channel may be reduced or increased as a function of time.
The apparatus may take a variety of forms. In one embodiment, the apparatus comprises a first channel containing a precipitation reagent, a second channel containing a sample for fractionation, and a semi-permeable membrane separating the first channel from the second channel.
Methods of separating target entities are also provided. In one embodiment, such a method comprises varying a concentration of a precipitation reagent from a first end of a channel to a second end of a channel, introducing a sample into the first end of the channel, and eluting the sample from the second end of the channel.
Embodiments of the invention will now be described with reference to the accompanying Figures, wherein like numerals refer to like elements throughout. The terminology used in the description presented herein is not intended to be interpreted in any limited or restrictive manner, simply because it is being utilized in conjunction with a detailed description of certain specific embodiments of the invention. Furthermore, embodiments of the invention may include several novel features, no single one of which is solely responsible for its desirable attributes or which is essential to practicing the inventions herein described.
Referring now to
Sample fractionation is advantageously performed by the presence of a precipitation reagent in the channel 10 that varies in concentration at different locations in the channel. In the embodiment illustrated in
As used herein, a precipitation reagent is any substance that renders a target entity either more or less soluble or mobile in the solvent contained in the channel. In some specific embodiments described below, an increase in the concentration of a precipitation reagent results in a decrease in the solubility in the channel solvent of one or more target species which are present in the sample to be fractionated. In other embodiments, an increase in the concentration of precipitation reagent increases the mobility of a target entity within the channel. In one embodiment described in detail herein, the precipitation reagent is ammonium sulfate, and the solvent in the channel 10 is water. Additional possibilities include sodium chloride or polyethylene glycols. A further alternative precipitation reagent for an aqueous channel solvent is any acid or base. This may create a pH gradient along the channel 10, and may be especially applicable to DNA and RNA fractionation. Non-aqueous channel solvent systems are also possible. For example, the channel solvent may comprise alcohol, and the precipitation reagent may be ether or hexane for example. This system may be advantageous for isolating a molecular species that is soluble in alcohol, but insoluble in a less polar solvent. A further alternative precipitation reagent, also described in more detail below, is a high molecular weight polymer such as hydroxyethyl starch, dextran, ficoll, gum arabic, albumin, as well as others. Varying concentrations of polymer can produce a density gradient along the channel 10, which can be especially advantageous in cell separation applications. The most advantageous choice of solvent and precipitation reagent will of course depend on the nature of the target molecule or entity and the other sample substances from which the target is to be isolated.
As mentioned above, a significant effect of the position dependent concentration of precipitation reagent in the channel 10 is that different entities that have different solubilities or mobilities in the presence of the precipitation reagent will precipitate or sediment out of the solvent at different locations within the channel 10. For example, a given sample introduced into the channel 10 may comprise three different protein species. A first protein may precipitate out of solution at an ammonium sulfate concentration of anything over 20% saturated. A second protein may precipitate out of solution at an ammonium sulfate concentration of anything over 40% saturated. A third protein may precipitate out of solution at an ammonium sulfate concentration of anything over 80%. If the concentration of ammonium sulfate increases from approximately 0% at the inlet 16, to approximately 100% saturated at the outlet 18, the first protein may be predominantly retained in the channel at approximately location 22 near the inlet 16, where the ammonium sulfate concentration passes through 20% saturated. Similarly, the second protein may be predominantly retained at approximately location 24, where the ammonium sulfate concentration passes through 40% saturated. The third protein may be predominantly retained at approximately location 26, where the ammonium sulfate concentration passes through 80% saturated. Thus, the three proteins are isolated from one another by the channel 10 of
A position dependent precipitation reagent concentration is created in the fractionation channel 34 by using a semi-permeable membrane for the partition 44, and by introducing a solution of the desired precipitation reagent into the second channel 48, which will be therefore referred to herein as the precipitation reagent channel 48. The precipitation reagent flows through the semi-permeable membrane 44 from the precipitation reagent channel 48 to the fractionation channel 34, as indicated by the arrows 60 of FIG. 2. The mass flow rate of precipitation reagent through the membrane 44 will be approximately proportional to the difference in precipitation reagent concentration at every point along the interface between the two channels 34, 48. In the general case, a steady state will be reached. If the fluid introduced into the inlet 36 of the fractionation channel 34 is free of precipitation reagent, a steady state concentration of precipitation reagent will be formed in the fractionation channel 34 which increases substantially continuously from the inlet end 36 to the outlet end 38. In addition, as precipitation reagent moves from the precipitation reagent channel 48 to the fractionation channel 34, the concentration of precipitation reagent in the second channel 48 will decrease substantially continuously from its inlet end 50 to its outlet end 52.
In one advantageous embodiment, the flow rate of the solution of precipitation reagent through the precipitation channel 48 is much greater than the flow rate of the fluid flowing through the fractionation channel 34. In this case, the concentration of precipitation reagent in the channel 48 remains approximately constant throughout its entire length because the rate that precipitation reagent is lost to the fractionation channel 34 is much lower than the rate at which precipitation reagent is introduced into the precipitation reagent channel 48.
As described above, such a gradient of precipitation reagent concentration in the fractionation channel 34 causes position dependent precipitation of molecular species to occur along the length of the channel 34. In advantageous embodiments, some of which are described in more detail below, a centrifugal force field transverse to the flow directions indicated by arrows 40, 56 in
Once separated along the channel length, these separated fractions may be eluted from the outlet end 38 of the fractionation channel 34 by timewise reduction in precipitation reagent concentration along the entire length of the fractionation channel 34. This may be accomplished by a timewise reduction in the concentration of precipitation reagent introduced into the precipitation reagent channel 48. This is illustrated in the graph of
It will be appreicated that this drop in precipitation reagent concentration in the fluid introduced into the channel 48 will produce a similar time dependent reduction of the concentration of precipitation reagent at any given point along the length of the fractionation channel 34. Although the concentration of precipitation reagent at any chosen location of the fractionation channel is decreasing, the position dependence of the concentration remains unchanged. Therefore, the increasing concentration gradient from the inlet 36 to the outlet 38 of the fractionation channel 34 is maintained over time, at least until no more precipitation reagent is being introduced into the precipitation reagent channel 48, and both channels 34, 48 have been flushed with clean solvent.
This has the advantageous effect that as the concentration of precipitation reagent is proportionally decreased in the fractionation channel 34, a molecular species precipitated at a given location will be dissolved and reprecipitated at a point slightly farther down the channel toward the oulet end 38. This dissolving, downward travel, and reprecipitation will occur repetitively as a given molecular species travels down the channel 34 until eluted at the outlet end 38 when the highest concentration of precipitation reagent in the fractionation channel 34 becomes too low to precpitate that species from the solvent. Thus, the molecular species introduced into the fractionation channel 34 are eluted in the order of their solubility in the presence of the precipitation reagent.
The inlet 36 of the fractionation channel 34 is fed by a source of solvent 70, which may be, for example, water. The solvent source 70 is coupled to a pump 72 which forces the solvent through the fractionation channel 34. In one embodiment, this pump is a commerically available syringe pump from, for example, Harvard Apparatus of Southnatick, Mass. Another syringe 74 may be used to inject samples to be fractionated into the fluid line 76 which feeds the inlet 36 of the fractionation channel 34. The outlet 38 of the fractionation channel feeds a fourth fluid line 78 that may be coupled to an appropriate detector 80. For protein fractionation, the detector may continuously measure the UV absorbance of the eluate as it is pumped through the channel 34. A suitable instrument is manufactured commercially by LKB Instruments in Stockholm, Sweden as the model Uvicord S, for instance. Of course, the nature of the detector 80 will vary depending on the nature of the molecular species being detected in the eluate.
Following detection, a multi-well fraction collector 82 may be utilized to separate fractions of the eluate. In pharmaceutical production applications of the invention, one or more fractions may be incorporated into a medicament, diagnostic kit, or other medical or pharmaceutical product. In applications involving biochemical research, the various fractions of eluate may be for collected for further evaluation with, for example, activity testing, electrophoretic analysis, or other analysis and characterization methods.
As mentioned above, it is advantageous to form a centrifugal force field in the channels 34, 48 transverse to the direction of flow through them. It is accordingly advantageous to form the channels 34 and 48 into a spiral or helical configuration so that they may be rotated around a common axis to produce the desired transverse centrifugal force. In one embodiment, this is performed by inserting a section of dialysis tubing into a flexible outer sleeve. The fractionation channel 34 then comprises the channel inside the dialysis tubing, and the region between the inner tubing and the outer sleeve comprises the precipitation reagent channel 48.
Another advantageous technique for accomplishing an easily centrifuged channel configuration is illustrated in FIG. 5. In this embodiment, the fractionation channel 34 is formed by cutting a spiral groove 84 into the surface of a plastic disk 86. The precipitation reagent channel 48 is formed by cutting a groove 88 into a second plastic disk 90. In one specific embodiment, the discs 86, 90 are made from polyethylene and are approximately 13.6 cm in diameter and 1.5 cm thick. In this embodiment, the grooves 84, 88 each may be approximately 1.5 mm wide, 2 mm deep, and have a total length of approximately 2 m. Each groove has a total volume of approximately 5 ml. The ends of the grooves 84, 88, are in fluid communication with fluid channels (not shown) within one or both discs 86, 90 to allow access to the inlet and outlet ends of both channels.
The two grooves 84, 88 may advantageously be formed as mirror images of one another so that when one disc 86 is placed on the other, the two grooves mate. As illustrated in
To produce the centrifugal field, the disc assembly of
In
The shaft of the motor 102 is coupled to the base of the gear box 106 by a drive belt 120. Thus, when the shaft of the motor 102 rotates at an angular velocity of ω, the entire gear box rotates at velocity ω on the stationary miter gear 104. This causes the horizontal miter gears 110, 112 to rotate at a speed of ω within their gearbox bearings 115. The rotation of the horizontal miter gears 110, 112 causes upper vertical miter gear 114 to rotate at a speed of ω relative to the gearbox 106. Thus, because the entire gearbox 106 is already rotating relative to the housing 100 at a speed of ω, the shaft of the upper miter gear rotates at a speed of 2ω relative to the housing.
To perform the centifugation, the discs 86, 90 are pressed tightly together between an upper aluminum plate 122 and a lower aluminum plate 124 and held together with screws 130 placed around the inner and outer periphery of the grooved sections of the discs 86, 90, thereby forming a leak free seal between the grooves 84, 88 and the membrane 94. This assembly is then mounted on the upwardly extending shaft of the upper miter gear 114 so as to rotate at a speed of 2ω relative to the housing 100. The four connecting tubes 58, 78, 66, 76, one for each end of each channel, are routed down through a hollow central portion of the shaft of the upper miter gear 114, and then out of the gearbox 106 through a hollow central portion of a horizontal miter gear 110. The connecting tubes then are routed up through one 116 of two arms 116, 118 and out an opening 132 in the top of the housing 100. In this embodiment no rotating seals are required, because the horizontal rotation of the tubes 58, 78, 66, 76 within the horizontal miter gear 110 cancels the other tube rotations relative to the housing 100 such that at the exit opening 132, no tube rotation is occurring. Centrifugation apparatus of this fundamental design is commercially available from Pharma-Tech Research Corporation of Baltimore Md. The elimination of rotating seals is especially advantageous in the present apparatus because cross flow and contamination at the connections between the inlet/outlet tubes and the spiral channels can be substantially avoided. The motor speed may of course vary widely depending on the diameter of the disk assembly and the desired application. For many applications, a motor speed of 500 to 700 RPM is suitable. In some advantageous embodiments, the motor speed is set at approximately 1000 RPM, thus resulting in a disc assembly 86, 90 rotation rate of 2000 RPM.
Preliminary experiments on the behavior of this fractionation apparatus determined that gravity plays an important role in ammonium sulfate transfer across the membrane 94. When the fractionation channel is the upper channel 84, the ammonium sulfate which migrates through the membrane 94 to the upper channel 84 remains over the membrane 94, thereby reducing the transfer efficiency. In contrast, when the fractionation channel is the lower channel 88, ammonium sulfate moves to the bottom of the fractionation channel after passing through the membrane 94 such that the less dense water solvent is exposed to the membrane surface and transfer efficiency is increased. Applying a centrifugal force field appears to enhance this affect, as ammonium sulfate in the fractionation channel is forced to the distal wall of the lower channel 84, thereby allowing increased net migration of ammonium sulfate across the remainder of the membrane.
It was also found that the greater the rate of solvent flow in the fractionation channel relative to the flow in the precipitation reagent channel, the lower the concentration of precipitation reagent in the eluate from the fractionation channel. If, for example, a 1 ml/min flow rate of 95% saturated ammonium sulfate is present in the precipitation channel and a 1 ml/min flow rate of water is present in the fractionation channel, the eluate from the fractionation channel is approximately 10% saturated with ammonium sulfate. In contrast, with a 0.1 ml/min flow rate of water in the fractionation channel, the eluate from the fractionation channel is near 90% saturated with ammonium sulfate.
Another phenomenon that has been noted to occur is that the output flow rate of the fractionation channel decreases as a percentage of the input flow rate as the input flow rate is decreased. This is due to solvent migration from the fractionation channel to the precipitation reagent channel, where it exits from the outlet of the precipitation reagent channel. At a 0.1 ml/min fractionation channel flow rate at the inlet, less than 0.25 ml/min is captured at the fractionation channel outlet. As will be described further below, however, no significant amount of target species appears to be lost to the precipitation reagent channel. Thus, this phenomenon helps to further concentrate the target species in the solvent eluate.
Turning now to
In the apparatus of
Using the same conditions as Example 1, a sample of 100 μl of pooled normal human serum in 1 ml of 50 mM potassium phosphate was introduced into the lower channel. A graph of absorbance as a function of time for this experiment is presented in FIG. 9. Once again, the albumin peak 148 is well resolved from the globulin peak 150.
The conditions for this purification protocol are the same as set forth in Example 1 above, except the starting concentration of ammonium sulfate in the upper channel was 75% saturated rather than 95% saturated, and a Perkin Elmer pump, rather than a Shimadzu pump, was used.
A 50 ml sample of hybridoma culture medium was obtained from Dr. Tadashi Okada, Department of Physiology, Aichi Medical University, Nagoya, Japan. The proteins in the crude supernatant were first concentrated by adding ammonium sulfate to 70% saturation to precipitate the target proteins. The sample was centrifuged, the supernatant was decanted, and the precipitate was redissolved in 2 ml of 50 mM potassium phosphate (pH 6.8). This 2 ml sample was introduced into the lower channel.
The absorbance at 275 nm as a function of time for this experiment is shown in FIG. 10. Albumin eluted in an initial peak 152. The antibodies were eluted in two peaks, an IgM peak 156, and an IgG peak 158. Activity testing with fractions collected in the IgM peak showed strong antibody activity of approximately 100 times that measured for the original crude sample.
Studies of reticulocyte proteins require the initial removal of hemoglobin, which typically represents over 99% of the proteins present in a raw reticulocyte lysate. Under experimental conditions as described in Example 3, a 1 ml sample of crude rabbit reticulocyte lysate was introduced into the lower channel. The 275 nm absorbance was measured as a function of time, with the results illustrated in FIG. 11. The hemoglobin is eluted in a first peak 162 at about 60% ammonium sulfate saturation on the upper channel. The remaining proteins are eluted in two smaller peaks 164, 166 at a lower ammonium sulfate concentration. A comparison of UV absorbance measurements at 260 nm and 280 nm of the fractions collected during the peak 166 indicated that RNA was eluted with protein at this time.
Using the protocol of Example 3, 10 mg of a mixture of lysozyme and lysozyme conjugated to polyethylene glycol (PEG5000) molecules was introduced into the lower channel. 275 nm absorbance data for this experiment is provided in FIG. 12. The lysozyme elutes in a first peak 168, while the conjugated lysozyme molecules elute in a second peak 170. Within the second peak 170, lysozyme molecules conjugated to different mumbers of PEG5000 molecules are partially resolved.
The separation protocol for recombinant ketosteroid isomerase (rKSI) from a crude E. coli lysate was performed under the conditions of Example 3, except the ammonium sulfate concentration in the upper channel was linearly dropped from 75% saturation to 25% saturation over 15 hours, at which time it was dropped straight to zero. The sample introduced was 0.5 ml E. coli lysate, containing approximately 1 mg rKSI protein. The results of this experiment are illustrated in FIG. 13. After elution of an unknown species or collection of species in an initial large peak 172, the rKSI eluted in a later peak 174 at approximately 50% saturated ammonium sulfate in the upper channel. However, the second peak 174 also contained many contaminating protein species other than the desired rKSI.
To improve the separation, approximately 25 mg of a specific affinity ligand β-estradiol-17-methyl-PEG-5000 was added to the sample. The results of the same separation protocol with the affinity ligand added to the sample shows a significant change in the elution pattern, which is illustrated in FIG. 14. With the added ligand, a small peak 180 elutes at a much later stage containing the protein-ligand complex. This peak is followed by a large peak 182 when free ligand exits the lower channel. SDS PAGE analysis of the collected fractions in both experiments showed a much lower concentration of contaminating proteins in the small peak 180 in the second experiment than in the rKSI containing peak 174 in the first experiment.
To test the tendency of sample species to migrate from the lower fractionation channel to the upper precipitation reagent channel, a membrane having a molecular weight cutoff of 6000-8000 daltons was used in the apparatus of
This finding opens up a rich domain of applications to the separation and purification of small molecules. For example, two mutually miscible organic solvents such as ether or hexane and ethanol can be used for fractional precipitation of analytes according to their differences in solubility in the different solvents, provided they are much more soluble in one solvent and than in the other.
The fundamental fractionation principles presented above and applied to protein separation may also be applied to cell separation. In this application, a polymeric precipitation reagent is used to create a density gradient from one end of a fractionation channel to other. Populations of different cell types introduced into this channel are sedimented in different locations along its length, and are accordingly eluted in order of increasing specific gravity when the solvent density along the entire channel is slowly increased.
As with the apparatus illustrated in
Referring now to
A cell separation protocol is initiated by flushing both upper channel 183 and the lower channel 185 with the phosphate buffer solution while rotating the channels in a centrifuge as shown in
As illustrated in
It is possible to perform a related cell separation protocol using a single channel. In this embodiment, a gradient pump has a high density polymer solution as one input and water or saline solution as a second input. The output of the gradient pump is coupled to the input of the sample channel 183. In this embodiment, a steadily increasing concentration of polymer is fed to the inlet 184 of the channel 183. In this method, sedimented cells will float out of the channel at the point where the density of the polymer solution rises to the critical density for the given cell type.
The dual channel embodiment has several advantages, however. First, in the dual channel design of
In addition, because of the exchange of water and polymer through the membrane, a circular flow in a plane transverse to the channel's longitudinal axis is generated at every point along the fractionation channel. This is illustrated in FIG. 17. Because of water migration up through the membrane 192, and polymer migration down through the membrane 192, the density of the solvent in the upper channel 183 is lower at the channel bottom 183a than it is at the channel top 183b. The higher density material at the upper region 183b is forced more strongly in the direction of the centrifugal force field (indicated by arrow 199) than is the lower density material near the membrane 192. Thus, flow toward the distal wall in the upper region 183a and flow away from the distal wall in the lower region is produced, resulting in a circular mixing effect in the channel 183. This mixing gently disperses the sedimented cells to help prevent packing and cell aggregation that interferes with effective fractionation.
Returning now to the molecular (rather than cellular) fractionation techniques, it will be appreciated that effective use of the fractionation apparatus and methods described above may be improved if it were possible to predict with some accuracy the retention times and peak widths of common protein species which need to be isolated from one another or from an unknown target molecule. Accurate data regarding such precipitation points is difficult to find in the literature, and may be somewhat different under the continuously variable precipitation reagent concentration conditions present in the fractionation channel.
To obtain useful data on this subject, a precipitation point analysis apparatus may be constructed as shown in FIG. 18. Referring now to this Figure, a gradient pump 200 has one inlet 202 coupled to a reservoir 204 of a high concentration of precipitation reagent, such as 90% saturated solution of ammonium sulfate. The second inlet 206 of the gradient pump 200 is coupled to a reservoir of protein solution for which information regarding precipitation properties is desired. The outlet 210 of the gradient pump 200, which has an output comprising a varying contribution from the first 202 and the second 206 inlets, feeds a detection cell 212, following which the detection cell 212 output is collected in a waste container 214.
With this apparatus, the contribution to the pump output from the source of precipitation reagent 204 may be increased over time, and the contribution to the pump output from the source of sample material 208 may be decreased over time. One embodiment of this pump 200 programming is illustrated in FIG. 19. In this Figure, the contribution to the output of the gradient pump which comes from the sample reservoir 208 is shown by curve 216 which begins at 1 or 100%. The contribution to the output of the gradient pump which comes from the precipitation reagent reservoir 204 is shown by curve 218 which begins at 0 or 0%. After a few minutes of 100% sample, the contribution from the precipitation reagent reservoir 204 is ramped up, partially replacing the sample solution, until the output of the gradient pump 200 is 100% precipitation reagent solution and no sample.
In operation, the UV absorbance of the eluate will initially fall as the concentration of protein in the output of the pump 200 drops. However, when the precipitation reagent concentration rises sufficiently, and the protein in the output begins to form a precipitate, light scattering will cause the absorbance reading to increase. Once all the protein in the eluate is precipitated completely, the absorbance reading will decrease again as the total concentration of protein in the eluate continues to fall to zero at the endpoint of the procedure. If desired, the detection cell may be flushed of precipitation reagent by recoupling the sample reservoir 208 to the pump output 210 for a few minutes following the conclusion of the procedure. This is illustrated in Example 8.
5 mg/ml human albumin was dissolved in plain water. A reservoir of this protein solution was coupled to one inlet of a Perkin-Elmer Series 200 gradient pump. The other inlet of the gradient pump was coupled to a reservoir of 90% saturated ammonium sulfate. The gradient pump total output was set to 0.1 ml per minute, and was programmed to draw output flow 100% from the protein reservoir for 3 minutes. Over the following 60 minutes, the output contribution from the protein reservoir was linearly ramped to zero, while the contribution from the ammonium sulfate reservoir was linearly ramped to 100%. For the following 5 minute period, the pump was programmed to again draw 100% from the protein reservoir.
The output of the gradient pump was continuously monitored at 280 nm by a Uvicord S absorbance monitor, the output of which is shown in FIG. 20. As described in general above, the absorbance of the eluate decreases until 27 minutes into the procedure, at an ammonium sulfate concentration of 56%. The elution curve reaches a maximum absorbance at 32 minutes, at an ammonium sulfate concentration of 68% saturated. The precipitation point for human albumin under the conditions of a continuously increasing ammonium sulfate gradient is thus determined to be approximately 62%.
The above technique was performed on a wide variety of protein species. Most of these proteins precipitate completely in a relatively narrow range of 10-12% difference in ammonium sulfate saturation of the output solution. Human albumin, illustrated in Example 8, is one such protein. Other proteins such as alpha-globulin and myoglobin showed broader or indistinct peaks which suggest sample heterogeneity. Cytochrome-c from horse heart showed no evidence of precipitation even at 90% ammonium sulfate saturation. Trypsinogen from bovine pancreas precipitated almost immediately at an ammonium sulfate concentration of less than 5% saturated. The effect on precipitation point due to changes in protein concentration has also been evaluated. For Isozyme, for example, it has been found that the precipitation point is stable at about 50-53% ammonium sulfate saturation in the concentration range of 2.5 to 10 mg/ml. As the protein concentration decreases below this level, however, the precipitation point increases to about 75% ammonium sulfate saturation at 0.1 mg/ml. It has also been found that the precipitation points of several proteins are pH dependent. This is illustrated in Example 9.
5 mg/ml solutions of the following proteins were subjected to the procedure of Example 8 at pH 4.5, 6.7, and 9.0: cytochrome-c, human albumin, ovalbumin, bovine hemoglobin, lysozyme, α-chymotrypsin, human α-globulin IV-1, human α-globulin IV-4, human β-globulin, human γ-globulin, bovine γ-globulin, and fibrinogen. The results are set forth in FIG. 21.
These proteins may be divided into two major groups. The hemoglobin and albumin which have a high precipitation point at approximately the 60-65% range, and the globulins and fibrinogen which have a relatively low precipitation point of approximately the 35-45% range. Proteins of the first group tend to have increasing precipitation points with increasing pH, whereas proteins of the second group generally show an opposite trend of decreasing precipitation points at high pH. This indicates that fractionation efficiency for samples containing mixtures of these types of proteins may be improved by performing the procedure at high pH.
The data shown in
In contrast, if the raw sample is a cell lysate containing many species of protein with intermediate precipitation values of, for example, 40% to 55%, a one step separation protocol may not be particularly effective. In these cases, a specific binding ligand which attaches to the target protein to modify its precipitation characteristics will likely improve the fractionation. A specific example of this situation is provided by Example 6 above.
The invention thus provides distinct advantages in terms of labor savings and purification efficiency. Effluent is monitored continuously as in liquid chromatography and the entire process can be automated. Very small samples may be purified in small capacity channels and collected in a concentrated state. Furthermore, the process may be easily scaled up for industrial use in the production of drugs, diagnostic assays, reagents, and other pharmaceutical products. The foregoing description details certain embodiments of the invention. It will be appreciated, however, that no matter how detailed the foregoing appears in text, the invention can be practiced in many ways. As is also stated above, it should be noted that the use of particular terminology when describing certain features or aspects of the invention should not be taken to imply that the terminology is being re-defined herein to be restricted to including any specific characteristics of the features or aspects of the invention with which that terminology is associated. The scope of the invention should therefore be construed in accordance with the appended claims and any equivalents thereof.
Patent | Priority | Assignee | Title |
9028693, | Dec 07 2007 | HEALTH AND HUMAN SERVICES, THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY | Apparatus for countercurrent chromatography |
Patent | Priority | Assignee | Title |
2986280, | |||
3065148, | |||
3352422, | |||
3399972, | |||
3617557, | |||
3840121, | |||
3856669, | |||
4147621, | Jun 28 1977 | UNIVERSITY OF UTAH RESEARCH FOUNDATION THE | Method and apparatus for flow field-flow fractionation |
4321138, | Feb 02 1981 | The United States of America as represented by the Department of Health | Method and apparatus for preparative countercurrent chromatography employing a rotating column assembly |
4322275, | Jan 10 1980 | Ionics Incorporated | Fractionation of protein mixtures |
4351710, | Jan 10 1980 | Ionics, Incorporated | Fractionation of protein mixtures |
4425112, | Feb 25 1976 | The United States of America as represented by the Department of Health | Flow-through centrifuge |
4551251, | Mar 06 1984 | The United States of America as represented by the Department of Health | Monolithic integrated flow circuit |
4623470, | Nov 09 1981 | ADLER, ROBERT J | Process and apparatus for separating or fractionating fluid mixtures |
4628204, | Aug 16 1984 | S.A. Texaco Belgium N.V. | Optical method to study the stability of colloidal systems |
4652364, | Apr 05 1985 | ERMA CR INCORPORATION | Apparatus for adjusting the concentration of a solution |
4741832, | May 15 1984 | TRUSTEES OF CLOUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE, A NY CORP | Purification apparatus and method employing a regenerable ligand |
4775476, | Nov 02 1987 | The Dow Chemical Company | Method for membrane assisted liquid chromatography |
4789468, | Aug 28 1984 | Trustees of the Stevens Institute of Technology | Immobilized-interface solute-transfer apparatus |
4794088, | Sep 25 1985 | Toyo Soda Manufacturing Co., Ltd. | Method and apparatus for separating and analyzing using liquid chromatography |
4874507, | Jun 06 1986 | SEPARATION TECHNOLOGIES, INC | Separating constituents of a mixture of particles |
4894146, | Jan 27 1986 | University of Utah, The | Thin channel split flow process and apparatus for particle fractionation |
4968428, | Nov 13 1987 | SLT CORPORATION | Centrifugal counter-current distribution chromatography |
5160625, | Jun 08 1988 | PHARMACIA LKB BIOTECHNOLOGY AB A COMPANY OF SWEDEN | Method for flow field flow fractionation |
5366622, | Sep 20 1990 | Passavant-Werke AG | Procedure and installation for conditioning and subsequent dewatering of sludge |
5434079, | Feb 12 1993 | UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HUMAN SERVICES | Apparatus and process for continuous in vitro synthesis of proteins |
5442175, | Sep 29 1994 | Advanced Micro Devices, Inc.; Advanced Micro Devices, INC | Gas evolution component analysis |
5468847, | Mar 10 1994 | Minnesota Mining and Manufacturing Company | Method of isolating and purifying a biomacromolecule |
5578204, | Oct 15 1992 | Apparatus for recovery and buffer exchange and/or concentration of dissolved macromolecules from a mixture of macromolecules | |
5595650, | Mar 03 1994 | Novartis Corporation | Device and a method for the separation of fluid substances |
5679231, | Feb 13 1995 | Gel bed dialyzer | |
5932100, | Jun 16 1995 | University of Washington | Microfabricated differential extraction device and method |
5961832, | Oct 22 1994 | Nuclear Decommissioning Authority | Method and apparatus for diffusive transfer between immiscible fluids |
27806, | |||
WO9731692, | |||
WO9739338, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Mar 05 1999 | The United States of America as represented by the Department of Health and Human Services | (assignment on the face of the patent) | / | |||
Apr 20 1999 | ITO, YOICHIRO | HEALTH AND HUMAN SERVICES, UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009985 | /0678 |
Date | Maintenance Fee Events |
Oct 31 2005 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Nov 08 2005 | ASPN: Payor Number Assigned. |
Dec 07 2009 | REM: Maintenance Fee Reminder Mailed. |
Apr 30 2010 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Apr 30 2005 | 4 years fee payment window open |
Oct 30 2005 | 6 months grace period start (w surcharge) |
Apr 30 2006 | patent expiry (for year 4) |
Apr 30 2008 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 30 2009 | 8 years fee payment window open |
Oct 30 2009 | 6 months grace period start (w surcharge) |
Apr 30 2010 | patent expiry (for year 8) |
Apr 30 2012 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 30 2013 | 12 years fee payment window open |
Oct 30 2013 | 6 months grace period start (w surcharge) |
Apr 30 2014 | patent expiry (for year 12) |
Apr 30 2016 | 2 years to revive unintentionally abandoned end. (for year 12) |